TaitDShanafeltMD

PubMed

• Ambient artificial intelligence scribes: utilization and impact on documentation time.
  Stephen P Ma, April S Liang, Shreya J Shah, Margaret Smith, Yejin Jeong
  Journal of the American Medical Informatics Association. 2024-12-17
• Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy era.
  Paul J Hampel, Kari G Rabe, Yucai Wang, Steven R Hwang, Saad S Kenderian
  Leukemia. 2024-12-10
• Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell Lymphocytosis.
  Bryan A Vallejo, Ahmed Ansari, Sameer A Parikh, Sara J Achenbach, Kari G Rabe
  Journal of Clinical Oncology. 2024-12-10

Journal Articles

• Assessment of the Association of Leadership Behaviors of Supervising Physicians with Personal-Organizational Values Alignment Among Staff Physicians  
  Tait D Shanafelt, Rick Majzun, Mickey Trockel, JAMA Network Open
• Assessment of Physician Sleep and Wellness, Burnout, and Clinically Significant Medical Errors  
  Mickey T Trockel, Susannah G Rowe, Mariah A Quinn, Daniel Marchalik, Patricia Normand, Mila Felder, Jessica C Dudley, Tait D Shanafelt, JAMA Network Open
• Association of Physician Burnout with Suicidal Ideation and Medical Errors  
  Tait D Shanafelt, Christine A Sinsky, Mickey T Trockel, JAMA Network Open
• Burnout, Depression, Career Satisfaction, and Work-Life Integration by Physician Race/Ethnicity  
  Tait D Shanafelt, Colin P West, Mickey T Trockel, Liselotte N Dyrbye, JAMA Network Open
• Resilience and Burnout Among Physicians and the General US Working Population  
  Colin P West, Liselotte N Dyrbye, Christine Sinsky, Tait D Shanafelt, JAMA Network Open
• Understanding and Addressing Sources of Anxiety Among Health Care Professionals During the COVID-19 Pandemic  
  Tait Shanafelt, Mickey Trockel, JAMA
• Association of Clinical Specialty with Symptoms of Burnout and Career Choice Regret Among US Resident Physicians  
  Mark Yeazel, Tait D Shanafelt, Liselotte N Dyrbye, JAMA
• Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukaemia Treated with Ibrutinib in Routine Clinical Practice at an Academic Medical Centre  
  Sameer A Parikh, Tait D Shanafelt, Paul J Hampel, Jose F Leis, Neil E Kay, Wei Ding, Timothy G Call, Deborah Bowen, Eli Muchtar, British Journal of Haematology
• Development of a Research Agenda to Identify Evidence-Based Strategies to Improve Physician Wellness and Reduce Burnout  
  Mickey Trockel, Christine A Sinsky, Liselotte N Dyrbye, Tait Shanafelt, Annals of Internal Medicine
• Join now to see all

Books/Book Chapters

• ACP MEDICINE 
  Chapter: Chronic Lymphoid Leukemias and Plasma Cell Disorders. 
  Shanafelt TD, Gertz MEditors: Elisabeth G. Nabel.2007
• Handbook of Disease Burdens and Quality of Life Measures 
  Chapter: Myeloproliferative Disorders and the Chronic Leukemias: Symptoms Burden and Impact on Quality of Life. 
  Mesa RA, Steensma DP, Shanafelt TDSpringer-Verlag2008
• Basics of Surgery 
  Chapter: Protecting and Promoting the Well-being of Surgeons. 
  Dyrbye L, Shanafelt TEditors: J.B.Trimbos.2007
• Mayo Clinic Medical Manual 
  Chapter: Thrombocytopenia. 
  Page 259 - 269Shanafelt T, Fonseca REditors: Oliveira GHM, Nesbitt GC, Murphy JG, et al..2006
• Mayo Clinic Medical Manual 
  Chapter: Neutropenia. 
  Page 661 - 665Shanafelt T, Fonseca REditors: Oliveira GHM, Nesbitt GC, Murphy JG, et al..2006
• ASCO Education Book 
  Chapter: Time Management and Burnout in Oncology. 
  Page 633 - 635Lyckholm LJ, Shanafelt TD, Ambrose HS, Chung HM2006
• Managing Breast Cancer Risk 
  Chapter: Improving Quality of Live for Breast Cancer Survivors: Non-Hormonal Treatment Options. 
  Page 227 - 238Shanafelt T, Loprinzi CEditors: M. Morrow and VC Jordan.BC Decker Inc., Hamilton2003
• Join now to see all

Abstracts/Posters

• Developmental DNA Methylation Subtype Predicts Progression to Treatment and Survival in High-Count Monoclonal B Lymphocytosis
  Tait D. Shanafelt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• The AKT Inhibitor MK2206 In Combination With Rituximab and Bendamustine Is Tolerable and Active In Relapsed Or Refractory Chronic Lymphocytic Leukemia: Results From a ...
  Wei Ding, MD, PhD, Shanafelt TD, Clive S. Zent, MD, Jose F. Leis, MD, PhD, Betsy R. LaPlant, Timothy G. Call, MD, Curtis A Hanson, Charles Erlichmanm, Thomas Habermann..., ASH Annual Meeting, 1/1/2013
• CD49d Is The Strongest Flow Cytometry-Based Predictor Of Overall Survival In Chronic Lymphocytic Leukemia.
  Pietro Bulian, MD, Shanafelt TD, Chris Fegan, MBBS, Antonella Zucchetto, Lilla Cro, PhD, Holger Nuckel, MD, Luca Baldini, Antonina Kurtova, MS, Alessandra Ferrajoli, M..., Blood, ASH Annual Meeting, 1/1/2013
• Outcomes Of Chronic Lymphocytic Leukemia Patients With Richter Syndrome.
  Sameer Parikh, Tschumper, Diane F. Jelinek, PhD, Neil E. Kay, MD, Susan L Slager, PhD, Kari G. Rabe, MS and Shanafelt TD, MD, Blood, ASH Annual Meeting, 1/1/2013
• Chronic Graft Vs Host Disease Is The Strongest Predictor Of Outcome After Reduced Intensity Conditioning Stem Cell Transplantation In Chronic Lymphocytic Leukemia and ...
  Saad Kenderian MD, Neil Kay, MD, Wei Ding, MD, PhD, Mark R. Litzow, MD, Kari G. Rabe, MS, William Hogan, MD and Shanafelt TD, Blood, ASH Annual Meeting, 1/1/2013
• Genomic Landscape and Clonal Heterogeneity Underlying Progression and Relapse In Chronic Lymphocytic Leukemia (CLL).
  Juhi Ojha, PhD, Jackline ayres-Silva, Charla Secreto, Scott Van Wier, Susan L Slager, PhD, Rafael Fonseca, M.D., Shanafelt TD, Neil E. Kay, MD and Esteban Braggio, Ph.D., Blood, ASH Annual Meeting, 1/1/2013
• Hypogammaglobulinemia In Patients With Previously Untreated Chronic Lymphocytic Leukemia: Clinical Correlates and Outcomes.
  Sameer A. Parikh, MD, Shanafelt TD, Kari G. Rabe, MS, Wei Ding, MD, PhD, Timothy G. Call, MD, Susan Schwager, Diane F. Jelinek, PhD, Neil Kay, MD, Jose F Leis MD, Blood, ASH Annual Meeting, 1/1/2013
• Hodgkin Transformation Of Chronic Lymphocytic Leukemia (CLL): Mayo Clinic Experience.
  Sameer A. Parikh, MD. Kari Rabe, Wei Ding, Timothy G. Call, Clive S Zent, Susan Schwager, Neil E kay, Jose F Leis, Susan L Slager, Shanafelt TD, Blood, ASH Annual Meeting, 1/1/2013
• Variability Of Performance Status Assessment Between Patients With Hematologic Malignancies and Their Physicians.
  Cristine Allmer, Matthew J Maurer, Shanafelt TD, James R Cerhan, Brian K Link, Carrie A Thompson, Blood, ASH Annual Meeting, 1/1/2013
• Clonal Evolution In Patients With Previously Untreated Chronic Lymphocytic Leukemia.
  Sameer A. Parikh, MD, Kari G. Rabe, MS, Blood, ASH Annual Meeting, 1/1/2013
• Heritable Predisposition To Richter Syndrome In Patients With Chronic Lymphocytic Leukemia.
  Sameer A. Parikh, MD, Susan L Slager, PhD, Kari G. Rabe, MS, Blood, ASH Annual Meeting, 1/1/2013
• Renal disease in patients with chronic lymphocytic leukemia.
  Shanafelt TD, Kari Rabe, Curtis Hanson, Timothy Call, Susan Schwager, Sameer Parikh, Samih Nasr, Nelson Leung, Blood, ASH Annual Meeting, 1/1/2013
• Minimal residual disease (mrd) detection in chronic lymphocytic leukemia (cll): flow cytometry (fc) or immunohistochemistry (ihc)?
  Amador-Orliz C, Menke DM, Valdez R, Jiang L, Michael TM, Morice WG, Jevremovic D, Shanafelt TD, Hanson CA, Lab Invest, 2/1/2012
• Minimal residual disease (MRD) detection in chronic lymphocytic leukemia (CLL): flow cytometry (FC) or immunohistochemistry (IHC)?
  Amador-Ortiz C, Menke DM, Valdez R, Jiang L, Michael TM, Morice WG, Jevremovic D, Shanafelt TD, Hanson CA, Mod Pathol, 2/1/2012
• Brief report PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium.
  Alexandra Nieters, Lucia Conde, Susan L. Slager,Angela Brooks-Wilson, Lindsay Morton Danica R. Skibola, Anne J. Novak, Jacques Riby, Stephen M. Ansell, Eran Halperin, ..., Blood, 1/1/2012
• Prognostic Relevance of CD49d Expression On B Leukemic Cells in Chronic Lymphocytic Leukemia. Meta-Analysis of Published and unpublished Individual Data From 3146 Pati...
  Pietro Bulian, Shanafelt TD, Chris Pepper, Chris Fegan, Giovanni Del Poeta, Gianluca Gaidano, Davide Rossi, Luca Baldini, Lilla Cro, Holger Nuckel, Jan A. Burger, Valt..., ASH Annual Meeting, 1/1/2012
• Extramedullary Chronic Lymphocytic Leukemia: Systematic Analysis of Cases Reported Between 1975 and 2010.
  Megan Ratterman, Kimberly Kruczek, Suela Sulo, Shanafelt TD, Timothy G. Call, Neil E. Kay, Chadi Nabhan, ASH Annual Meeting, 1/1/2012
• Risk of Cancer in Patients with Clinical Monoclonal B-Cell Lymphocytosis (MBL): A Cohort Study of Newly Diagnosed Patients Compared to Controls.
  Benjamin M Solomon, Kari G. Rabe, Jonathan Moreira, Susan Schwager, James R Cerhan, Timothy G. Call, Neil E. Kay, Susan L Slager, Shanafelt TD, ASH Annual Meeting, 1/1/2012
• Chronic Lymphocytic Leukemia in Young (<= 55 years) Patients: A Comprehensive Analysis of Prognostic Factors and Outcomes.
  Sameer A. Parikh, Kari G. Rabe, Neil E. Kay, Timothy G. Call, Wei Ding, Susan Schwager, Diane F. Jelinek, Susan L Slager, Shanafelt TD, ASH Annual Meeting, 1/1/2012
• Transformation of Chronic Lymphocytic Leukemia Into Diffuse Large B-Cell Lymphoma (Richter's Syndrome): Large Retrospective Analysis From a Single Institution.
  Sameer A. Parikh, Kari G. Rabe, Neil E. Kay, Clive S. Zent, Timothy G. Call, Wei Ding, Curtis A. Hanson, William R Macon, Susan Schwager, Diane F. Jelinek, Susan L Sla..., ASH Annual Meeting, 1/1/2012
• Very High Risk CLL Characterized by a "Double Hit" Clone with Both 11q22 and 17p13 Deletion.
  Patricia T. Greipp, Stephanie A. Smoley, David S. Viswanatha, Lori S. Frederick, Ruchi G. Sharma, Kari G. Rabe, Susan L Slager, Daniel L. Van Dyke, Neil E. Kay, Shanaf..., ASH Annual Meeting, 1/1/2012
• The Impact of Race, Age, and Sex in Chronic Lymphocytic Leukemia (CLL): A Comprehensive SEER Analysis in the Pre and Post Rituximab (R) Eras.
  Chadi Nabhan, Briseis Aschebrook-Kilfoy, Andrew M. Evens, Brian C-H Chiu, Sonali M. Smith, Shanafelt TD, Neil E. Kay, ASH Annual Meeting, 1/1/2012
• Clonal Chromosomal Anomalies Similar to CLL and Other Hematologic Malignancies Can Be Found in "Normal" Individuals.
  Cathy C Laurie, Cecelia A Laurie, Brooke Fridley, Erin Carlson, Stephanie A. Smoley, Ian W. Flinn, Martin S. Tallman, Elisabeth Paietta, Richard Weinshilboum, Neil E. ..., ASH Annual Meeting, 1/1/2012
• What Numbers Don't Say: Immunogenetic Evidence Shows That High-Count MBL Resembles Rai 0 CLL While Low-Count MBL Does Not.
  Anna Vardi, Antonis Dagklis, Lydia Scarfo, Diane F. Jelinek, Darren J Newton, Chi Doughty, Julia Almeida, Arancha Rodriguez-Caballero, Sallie D. Allgood, Mark C. Lanas..., ASH Annual Meeting, 1/1/2012
• In Patients Newly Diagnosed with Chronic Lymphocytic Leukemia the Absolute Monocyte Count At Presentation Is Directly Associated with Disease Progression Independently...
  Wilcox RA, Rabe K, Kay NE, Call TG, Markovic SN, Porrata LF, Schwager S, Zent CS, Hanson CA, Shanafelt TD, Blood (ASH Annual Meeting), San Diego, CA, 11/1/2011
• Join now to see all

Lectures

• 50th Annual Louis F. Bishop Keynote: Reducing Burnout and Promoting Engagement: Individual and Organizational Approaches to Physician Well-being 
  2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
• Clinician Wellness Intensive I Featuring the 50th Annual Louis F. Bishop Keynote 
  2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
• Ibrutinib-Based Therapy Improves Anti-Tumor T Cell Killing Function Allowing Effective Pairing with Anti-PD-L1 Immunotherapy Compared to Traditional FCR Chemoimmunothe... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Telomere Length Is Associated with Epigenetic Programming in CLL and Is a Superior Predictor of Clinical Outcome with the Ability to Bifurcate Patients with the Same C... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Self-Care in Health Care: Surviving and Thriving 
  60th American Society of Hematology Annual Meeting - 11/30/2018
• "Highlights of ASH: Chronic Lymphocytic Leukemia." 
  San Francisco - 1/17/2014
• "Predi Treatment of older patients with chronic lymphocytic leukemia: key questions and current answers." 
  New Orleans, LA - 12/7/2013
• "Physician Well-being and Professionalism." 
  Philadelphia - 9/16/2013
• "Monoclonal B-cell Lymphocytosis: What Matters Clinically." 
  Cologne, Germany - 9/10/2013
• Education Session: "Management CLL" 
  Lugano, Switzerland - 6/21/2013
• Key Note Address: "Finding Meaning, Balance and Personal Satisfaction in the Practice of Medicine." 
  Mayo Clinic Department Neurology - 5/30/2013
• "Finding Meaning, Balance and Personal Satisfaction in the Practice of Medicine." 
  Jordan Medical Center - 5/29/2013
• Keynote Address: "Avoiding Burnout and Finding Personal Satisfaction in the Practice of Medicine." 
  St. Anthony's Hospital - 5/2/2013
• Grand Rounds: . "Finding Meaning, Balance and Personal Satisfaction in the Practice of Medicine." 
  Cleveland Clinic Cancer Center - 3/1/2013
• Mayo Emergency Medicine Grand Rounds: "Avoiding Burnout and Finding Personal Satisfaction in the Practice of Medicine." 
  Rochester, MN - 10/30/2012
• "Finding Meaning, Balance, and Personal Satisfaction in the Practice of Medicine". (Keynote Speaker) 
  Montreal - 10/25/2012
• Early Stage CLL: Toward a New Paradigm. (Keynote Speaker) 
  Winnepeg, Manitoba - 10/3/2012
• Mayo Critical Care Grand Rounds: "Avoiding Burnout and Finding Personal Satisfaction in the Practice of Medicine." 
  Rochester, MN - 5/17/2012
• Education Session: Targeting the B-cell receptor signaling pathway: a new frontier for CLL." 
  Boston, MA - 5/6/2012
• "CLL 2012: Role of Age, Diet, and Environment on Management of Early Stage Patients" 
  Glasgow, Scotland - 4/17/2012
• "Finding Meaning, Balance, and Personal Satisfaction in the Practice of Medicine". 
  Dallas, TX - 4/14/2012
• "Management of Elderly Patients with CLL". 
  Lake Louis, Canada - 3/16/2012
• "Chronic Lymphocytic Leukemia". 
  Prime Oncology, Hollywood, FL - 2/25/2012
• "Physician Burnout: Implications for Professional Development and Quality of Care." 
  Chicago - 1/13/2012
• "CLL ASH Update 2011" 
  Scottsdale, AZ - 1/1/2012
• Join now to see all